Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
International Psychogeriatrics
|
February 9, 2025
Can neuromodulation alleviate cognitive deficits?
Miklos Argyelan, Sohag Sanghani
The Psychiatric Clinics of North America
|
February 27, 2022
The Impact of COVID-19 on Brain Stimulation Therapy
Michael Justin Coffey, Suzanne Kerns, Sohag Sanghani, et al.
Journal of the Academy of Consultation-Liaison Psychiatry
|
August 10, 2022
Adolescents and Young Adults With Anti-N-methyl-D-aspartate Receptor Encephalitis With Excited Catatonia: Literature Review and 2 Illustrative Cases
Eva Levy, Paloma Reinoso, Humaira Shoaib, et al.
The Journal of ECT
|
September 14, 2021
Electroconvulsive Therapy in the Epicenter of COVID-19: Experiences and Reflections
Sohag Sanghani, Kristy Loewenstein, Jason Andrus, et al.
International Clinical Psychopharmacology
|
February 10, 2017
Indications for and use of long-acting injectable antipsychotics: consideration from an inpatient setting
Taishiro Kishimoto, Sohag Sanghani, Mark J Russ, et al.
Translational Psychiatry
|
October 9, 2021
ECT-induced cognitive side effects are associated with hippocampal enlargement
Miklos Argyelan, Todd Lencz, Simran Kang, et al.
Focus (American Psychiatric Publishing)
|
February 5, 2020
Electroconvulsive Therapy Augmentation in Clozapine-Resistant Schizophrenia: A Prospective, Randomized Study
Georgios Petrides, Chitra Malur, Raphael J Braga, et al.
The American Journal of Psychiatry
|
August 27, 2014
Electroconvulsive therapy augmentation in clozapine-resistant schizophrenia: a prospective, randomized study
Georgios Petrides, Chitra Malur, Raphael J Braga, et al.
Journal of Neuroimmunology
|
July 27, 2024
Correspondence: Electroconvulsive therapy in N-methyl-D-aspartate receptor encephalitis
Jonathan Reed Komisar, Sohag Sanghani, Grace Thrall, et al.
The Journal of ECT
|
February 27, 2022
Simulated Electroconvulsive Therapy: A Novel Approach to a Control Group in Clinical Trials
Kaitlin R McManus, Maria I Lapid, Brent P Forester, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
International Psychogeriatrics
|
February 9, 2025
Can neuromodulation alleviate cognitive deficits?
Miklos Argyelan, Sohag Sanghani
The Psychiatric Clinics of North America
|
February 27, 2022
The Impact of COVID-19 on Brain Stimulation Therapy
Michael Justin Coffey, Suzanne Kerns, Sohag Sanghani, et al.
Journal of the Academy of Consultation-Liaison Psychiatry
|
August 10, 2022
Adolescents and Young Adults With Anti-N-methyl-D-aspartate Receptor Encephalitis With Excited Catatonia: Literature Review and 2 Illustrative Cases
Eva Levy, Paloma Reinoso, Humaira Shoaib, et al.
The Journal of ECT
|
September 14, 2021
Electroconvulsive Therapy in the Epicenter of COVID-19: Experiences and Reflections
Sohag Sanghani, Kristy Loewenstein, Jason Andrus, et al.
International Clinical Psychopharmacology
|
February 10, 2017
Indications for and use of long-acting injectable antipsychotics: consideration from an inpatient setting
Taishiro Kishimoto, Sohag Sanghani, Mark J Russ, et al.
Translational Psychiatry
|
October 9, 2021
ECT-induced cognitive side effects are associated with hippocampal enlargement
Miklos Argyelan, Todd Lencz, Simran Kang, et al.
Focus (American Psychiatric Publishing)
|
February 5, 2020
Electroconvulsive Therapy Augmentation in Clozapine-Resistant Schizophrenia: A Prospective, Randomized Study
Georgios Petrides, Chitra Malur, Raphael J Braga, et al.
The American Journal of Psychiatry
|
August 27, 2014
Electroconvulsive therapy augmentation in clozapine-resistant schizophrenia: a prospective, randomized study
Georgios Petrides, Chitra Malur, Raphael J Braga, et al.
Journal of Neuroimmunology
|
July 27, 2024
Correspondence: Electroconvulsive therapy in N-methyl-D-aspartate receptor encephalitis
Jonathan Reed Komisar, Sohag Sanghani, Grace Thrall, et al.
The Journal of ECT
|
February 27, 2022
Simulated Electroconvulsive Therapy: A Novel Approach to a Control Group in Clinical Trials
Kaitlin R McManus, Maria I Lapid, Brent P Forester, et al.
Page
of 2